Cytodyn Inc (CYDY)

[TheBioTechG]

Not to distract from the company, but dlcullum said he has a position in CYDY and is trying to argue for what could be opposing us. I'm taking him at face value on that, but like I said in my previous post - his negativity is overly slanted. I'll often take the same approach when debating a topic by arguing against my own viewpoint so I can see both sides.

All of that aside, I believe our major hurdles/roadblocks are (in no specific order):

-Regulatory delays
-Lack of exposure (especially for filling clinical trials)
-Bureaucracy
-Ibalizumab (because they are in a phase I, self administered clinical trial)
-CRISPR (I won't take the time to explain this because they are not even doing human trials, but they are also presenting at the ASM conference)

The science for PRO 140 is there and that is the most important part. I believe that if/when PRO 140 is approved, that it will be the new standard of care for those patients with the R5 tropism.